Clinical Trials Sponsored by Bavarian Nordic

Total 2724 results

Turku University Hospital
Nordic Urothelial Cancer Group

Recruiting

Nordic Cystectomy Study I - Neutrophil-lymphocyte Ratio (NLR) (NorCys-NLR)

Bladder Cancer | Invasive Bladder Cancer

Finland
Oslo University Hospital
Nordic Myeloma Study Group

Active, not recruiting

Intensified Treatment With Carfilzomib in Myeloma Patients Still PET-positive After First Line Treatment. (CONPET)

Myeloma

Norway, Denmark, Sweden
University of Copenhagen
The Novo Nordic Foundation

Unknown

Pain Phenotyping of Patients With Bone Cancer Pain (BonemetPAIN)

Pain | Metastatic Breast Cancer | Bone Metastases

Denmark
Symic OA Co.
Nordic Bioscience A/S

Completed

A Trial of a Single Delivery of SB-061 in Osteoarthritis of the Knee (MODIFY2)

Osteoarthritis

Estonia
University of Aarhus
The Novo Nordic Foundation

Completed

Sedation Influence on Delirium and Post-traumatic Stress-disorder as a Result of Hospitalization in Intensive Care

Delirium | Stress Disorders, Post-Traumatic

Denmark
Nordic Myeloma Study Group
Janssen-Cilag Ltd.

Completed

Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients

Multiple Myeloma

Norway, Sweden, Denmark, Finland, Iceland
Fox Chase Cancer Center
Varian Medical Systems

Withdrawn

Local Consolidative Therapy in Colorectal Cancer

Colorectal Cancer Metastatic

United States
Palo Alto Veterans Institute for Research
Varian

Not yet recruiting

Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee (MRI)

Osteoarthritis, Knee | Osteoarthritis, Hip | Pain, Chronic | Synovitis | Osteo Arthritis Shoulders | Synovitis of Knee | Synovitis/Tenosynovitis - Hip

United States
Stanford University
Varian, a Siemens Healthineers Company

Active, not recruiting

Lung Volume Reduction for Severe Emphysema by Stereotactic Ablative Radiation Therapy

Emphysema

United States
M.D. Anderson Cancer Center
Varian Medical Systems

Completed

Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy

Lung Cancer

United States
Kurt Weiss
Stryker Nordic

Recruiting

Fluorescent Intra-operative Tumor Margin Examination (ICGTM)

Sarcoma

United States
Turku University Hospital
Nordic Urothelial Cancer Group

Recruiting

Nordic Cystectomy Study II - Albumin (NorCys-Alb)

Bladder Cancer | Invasive Bladder Cancer

Finland
Bone Therapeutics S.A
Nordic Bioscience A/S

Completed

Phase III Study on the Safety and Efficacy of a Single Intra-articular Administration of JTA-004 in Symptomatic Knee Osteoarthritis (JTA-KOA2)

Symptomatic Osteoarthritis of the Knee

Denmark, Belgium, United Kingdom, Czechia, Hong Kong, Moldova, Republic of, Poland
University of Aarhus
DePuy Orthopaedics; Stryker Nordic

Active, not recruiting

Study of Knee Replacements for Patellofemoral Osteoarthritis (PFA/TKR)

Osteoarthritis, Knee

Denmark
Dutch Colorectal Cancer Group
Nordic Pharma SAS

Completed

S-1 Versus Capecitabine in the First Line Treatment of MCC Patients. (SALTO)

Colorectal Cancer | Metastases

Netherlands
Symic OA Co.
Nordic Bioscience Clinical Development

Completed

A Trial of SB-061 in Osteoarthritis of the Knee (MODIFY-OA)

Osteoarthritis

Estonia
The Nordic Network For Clinical Islet Transplantation

Unknown

Intraportal or Intramuscular Site for Islets in Simultaneous Islet and Kidney Transplantation

Type 1 Diabetes | End Stage Renal Disease
Nordic Myeloma Study Group
Janssen-Cilag Ltd.

Unknown

Bortezomib and High-dose Melphalan at Myeloma Relapse

Multiple Myeloma

Denmark, Norway, Sweden
Cordio Medical

Recruiting

AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM (DETECT-HF)

Heart Failure

United States, Israel
Cordio Medical

Recruiting

R&D Study to Evaluate Cordio's Usability and to Collect Patient Speech Utterances

Chronic Heart Failure

United States, Israel
Novoic Limited

Recruiting

Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension (FUTURE-US)

Alzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's Disease

United States
Novoic Limited

Recruiting

Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension (PAST-US)

Alzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's Disease | Normal Cognition

United States
Novoic Limited

Recruiting

Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - PAST Extension (AMYPRED-PAST)

Alzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's Disease

United Kingdom
Cordis Corporation

Completed

European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INSIGHT)

Abdominal Aortic Aneurysms

United Kingdom, Netherlands, Ireland, Sweden, Germany, Italy, Spain, France
Novoic Limited

Terminated

Assessing Performance on Speech Tasks Via Crowdsourced Participants (AMYWEB)

Cognitive Impairment | Mild Cognitive Impairment

United Kingdom
Novoic Limited

Completed

Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping (AMYPRED-US)

Alzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's Disease

United States
Cordio Medical

Completed

Remote Speech Analysis in HF Patients Undergoing Haemodialysis

Heart Failure

Israel
Cordis Corporation

No longer available

Compassionate Use of the Incraft® AAA Stent Graft System

Abdominal Aortic Aneurysm

United States
Cordis Corporation

Completed

S.M.A.R.T.® Nitinol Self-Expandable Stent in the Treatment of Obstructive Superficial Femoral Artery Disease (STROLL)

Superficial Femoral Artery Disease

United States
Cordis Corporation

Terminated

An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II) (NEVO II)

Atherosclerotic Coronary Artery Disease

Spain, Switzerland, Netherlands
Cordis Corporation

Completed

The Intra-Drug Eluting Stent (DES) Restenosis Study (CRISTAL)

Coronary Artery Disease

France
Cordis Corporation

Completed

The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ Stent (SUPER SL)

Arterial Occlusive Diseases

Germany
Cordis Corporation

Completed

A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions (SCORPIUS)

Coronary Artery Disease

Germany
Cordis Corporation

Completed

Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions (3D)

Coronary Artery Disease

Brazil
Cordis Corporation

Completed

Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)

Coronary Artery Disease

United States
Cordis Corporation

Completed

The Study to Assess AMI Treated With Balloon Angioplasty. (TYPHOON)

Coronary Artery Disease

France, Germany
Cordis Corporation

Completed

The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions. (E-SIRIUS)

Coronary Artery Disease

Germany
Cordis Corporation

Completed

Protection From Pulmonary Embolism With the Permanent OptEase™ Filter (PROOF)

Pulmonary Embolism
Cordis Corporation

Completed

Distal Protection Combined With PTCA in AMI Patients (DIPLOMAT)

Coronary Artery Disease

France
Cordis Corporation

Completed

FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent

Coronary Artery Disease

Netherlands
Novoic Limited

Recruiting

Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - FUTURE Extension (AMYPRED-FUTURE)

Alzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's Disease

United Kingdom
Cordio Medical

Recruiting

COMMUNITY STUDY- A Study to Collect Information for the Cordio System

Heart Failure

Israel
Cordis Corporation

Completed

A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION) (INNOVATION)

Abdominal Aortic Aneurysms

Germany
Cordis Corporation

Completed

SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy

Carotid Artery Disease

United States
Cordis Corporation

Unknown

Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems (ELITE)

Coronary Artery Disease | Coronary Atherosclerosis

United States
Cordis Corporation

Terminated

Cynergy: the CYPHER-NEVO Registry (CYNERGY)

Coronary Artery Disease

Korea, Republic of, Brazil, Switzerland
Cordis Corporation

Completed

Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease (ACHILLES)

Peripheral Arterial Diseases

Germany
Cordis Corporation

Completed

A Study of the SMART Stent in the Treatment SFA Disease. (SIROCCO)

Peripheral Artery Disease

Germany
Cordis Corporation

Completed

A Multi-center Post-Market Surveillance Registry (E-SELECT)

Coronary Artery Disease

Switzerland
Cordis Corporation

Completed

Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)

In-Stent Restenosis

United States

Clinical Trials Sponsored by Bavarian Nordic

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations